Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. (Q48488976)
Jump to navigation
Jump to search
scientific article published in June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. |
scientific article published in June 2006 |
Statements
1 reference
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. (English)
1 reference
S Schimrigk
1 reference
N Brune
1 reference
K Hellwig
1 reference
C Lukas
1 reference
B Bellenberg
1 reference
M Rieks
1 reference
V Hoffmann
1 reference
D Pöhlau
1 reference
H Przuntek
1 reference
1 June 2006
1 reference
1 reference
13
1 reference
604-610
1 reference
6
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference